chr13:28874483:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr13:28,874,483-29,069,282 |
| hg38 | chr13:28,300,346-28,495,145 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| 0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
| 0.002 | chorioamnionitis | NA | GAD | Detail | |
| <0.001 | choriocarcinoma | NA | BeFree | Detail | |
| <0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| <0.001 | ulcerative colitis | NA | BeFree | Detail | |
| <0.001 | Colonic Neoplasms | NA | BeFree | Detail | |
| 0.003 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.120 | Coronary heart disease | NA | GWASCAT | Detail | |
| 0.080 | Dementia, Vascular | NA | RGD | Detail | |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| 0.003 | Diabetic Nephropathy | NA | BeFree,LHGDN | Detail | |
| 0.081 | diabetic retinopathy | NA | BeFree,RGD | Detail | |
| 0.001 | eclampsia | NA | BeFree | Detail | |
| <0.001 | Ependymoma | NA | BeFree | Detail | |
| <0.001 | Esophageal Neoplasms | NA | BeFree | Detail | |
| <0.001 | Exanthema | NA | BeFree | Detail | |
| 0.005 | Fetal Growth Retardation | NA | GAD,LHGDN | Detail | |
| 0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
| <0.001 | fibrosarcoma | NA | BeFree | Detail | |
| <0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
| 0.001 | glioblastoma | NA | BeFree | Detail | |
| 0.002 | Glioma | NA | BeFree | Detail | |
| <0.001 | goiter | NA | BeFree | Detail | |
| 0.003 | Granuloma | NA | LHGDN | Detail | |
| 0.003 | hemangioma | NA | BeFree,LHGDN | Detail | |
| 0.120 | Hemangiosarcoma | NA | CTD_human | Detail | |
| <0.001 | hepatitis C | NA | BeFree | Detail | |
| <0.001 | Von Hippel-Lindau syndrome | NA | BeFree | Detail | |
| 0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
| <0.001 | Hypertensive disease | NA | BeFree | Detail | |
| <0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
| 0.003 | Inflammation | NA | LHGDN | Detail | |
| <0.001 | ischemia | NA | BeFree | Detail | |
| <0.001 | arthropathy | NA | BeFree | Detail | |
| <0.001 | Kidney Diseases | NA | BeFree | Detail | |
| 0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
| 0.004 | leukemia | NA | BeFree,LHGDN | Detail | |
| 0.003 | chronic lymphocytic leukemia | NA | BeFree,LHGDN | Detail | |
| 0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| 0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.003 | myeloid leukemia | NA | BeFree,LHGDN | Detail | |
| <0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
| 0.200 | liver cirrhosis | NA | BeFree,CTD_human,RGD | Detail | |
| <0.001 | Chronic Obstructive Airway Disease | Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic ... | BeFree | 24891316 | Detail |
| 0.003 | Lung Neoplasms | NA | LHGDN | Detail | |
| 0.003 | Lupus Erythematosus, Systemic | NA | LHGDN | Detail | |
| 0.005 | Lymphoma, Non-Hodgkin | NA | GAD,LHGDN | Detail | |
| <0.001 | macular degeneration | NA | BeFree | Detail | |
| 0.003 | Malaria, Cerebral | NA | LHGDN | Detail | |
| 0.002 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| <0.001 | medulloblastoma | In a retrospective collection of 44 cases (14 astrocytoma, 16 ependymoma and 14 ... | BeFree | 24190638 | Detail |
| 0.131 | melanoma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Melanoma, Experimental | NA | BeFree | Detail | |
| <0.001 | Mesothelioma | NA | BeFree | Detail | |
| <0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
| 0.003 | Mucocutaneous Lymph Node Syndrome | NA | BeFree,LHGDN | Detail | |
| 0.004 | multiple myeloma | NA | BeFree,LHGDN | Detail | |
| <0.001 | myelofibrosis | NA | BeFree | Detail | |
| 0.081 | myocardial infarction | PHACTR1, CDKN2B-AS1, LPL, PSRC1, FLT1 and CNNM2 may thus be susceptibility loci ... | BeFree,RGD | 25738804 | Detail |
| 0.128 | Neoplasm Metastasis | Nuclear FGFR2 expression was associated with increased risk of metastasis (odds ... | BeFree,CTD_human,LHGDN | 24390213 | Detail |
| 0.128 | Neoplasm Metastasis | Lymphocyte-associated VEGFR-1 expression in the invasive front without accompany... | BeFree,CTD_human,LHGDN | 25880726 | Detail |
| 0.128 | Neoplasm Metastasis | Moreover, we found that the soluble Flt-1 from SWT neutralized the increased pla... | BeFree,CTD_human,LHGDN | 25895458 | Detail |
| 0.128 | Neoplasm Metastasis | Importantly, FLT1 inhibition reduces tumor metastatic efficiency even after init... | BeFree,CTD_human,LHGDN | 26261265 | Detail |
| 0.002 | Pathologic Neovascularization | NA | GAD | Detail | |
| <0.001 | nephrotic syndrome | NA | BeFree | Detail | |
| 0.003 | neurilemmoma | NA | LHGDN | Detail | |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Neurofibromatosis 2 | NA | BeFree | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| <0.001 | oligodendroglioma | NA | BeFree | Detail | |
| <0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
| 0.120 | Osteochondrodysplasias | NA | CTD_human | Detail | |
| <0.001 | osteosarcoma | In addition, it was demonstrated that VEGF and VEGFR1 are coexpressed by a subse... | BeFree | 24759089 | Detail |
| 0.080 | Otitis Media with Effusion | NA | RGD | Detail | |
| 0.002 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.003 | Ovarian Cysts | NA | LHGDN | Detail | |
| 0.003 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
| <0.001 | paraganglioma | Discordant results were observed for VEGFR1, p27, and p21 overexpressed in parag... | BeFree | 24390213 | Detail |
| <0.001 | pituitary adenoma | We investigated the expression of p53, Ki-67, Bax, Bcl-2, vascular endothelial g... | BeFree | 25109698 | Detail |
| <0.001 | placental insufficiency | NA | BeFree | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| 0.168 | pre-eclampsia | NA | CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Preleukemia | NA | BeFree | Detail | |
| 0.003 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | psoriasis | NA | BeFree | Detail | |
| <0.001 | pterygium | NA | BeFree | Detail | |
| <0.001 | Rectal Neoplasms | NA | BeFree | Detail | |
| <0.001 | kidney failure | NA | BeFree | Detail | |
| <0.001 | retinoblastoma | NA | BeFree | Detail | |
| <0.001 | retinopathy of prematurity | NA | BeFree | Detail | |
| <0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
| 0.003 | sarcoidosis | NA | BeFree,GAD | Detail | |
| <0.001 | Sarcoidosis, Pulmonary | NA | BeFree | Detail | |
| 0.003 | systemic scleroderma | NA | BeFree,GAD | Detail | |
| 0.122 | Skin Neoplasms | NA | CTD_human,GAD | Detail | |
| 0.005 | Stomach Neoplasms | NA | LHGDN | Detail | |
| <0.001 | gastric ulcer | NA | BeFree | Detail | |
| <0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
| <0.001 | Testicular Neoplasms | NA | BeFree | Detail | |
| <0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
| <0.001 | Thyroid Neoplasm | NA | BeFree | Detail | |
| <0.001 | tuberous sclerosis | NA | BeFree | Detail | |
| 0.120 | uremia | NA | CTD_human | Detail | |
| <0.001 | Varicosity | NA | BeFree | Detail | |
| <0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
| 0.003 | ovarian hyperstimulation syndrome | NA | LHGDN | Detail | |
| 0.080 | corneal neovascularization | NA | RGD | Detail | |
| <0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
| 0.002 | Bronchial Hyperreactivity | NA | GAD | Detail | |
| 0.002 | bacterial vaginosis | NA | GAD | Detail | |
| 0.003 | Liver failure | NA | LHGDN | Detail | |
| <0.001 | Synovial Cyst | NA | BeFree | Detail | |
| <0.001 | acute leukemia | NA | BeFree | Detail | |
| 0.005 | Premature Birth | NA | GAD | Detail | |
| <0.001 | gastrointestinal carcinoma | NA | BeFree | Detail | |
| <0.001 | esophageal carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of anus | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | retinal ischemia | NA | BeFree | Detail | |
| <0.001 | HELLP syndrome | NA | BeFree | Detail | |
| 0.002 | Tumor Progression | No significant risk for developing tumor progression was associated with Ki-67, ... | BeFree | 25109698 | Detail |
| 0.002 | Tumor Progression | The VEGFR-1 is suggested to promote tumor progression. | BeFree | 25894226 | Detail |
| <0.001 | Germ cell tumor | NA | BeFree | Detail | |
| <0.001 | adenosquamous carcinoma | NA | BeFree | Detail | |
| <0.001 | Liposarcoma, Myxoid | NA | BeFree | Detail | |
| <0.001 | teratocarcinoma | NA | BeFree | Detail | |
| <0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | mucoepidermoid carcinoma | NA | BeFree | Detail | |
| <0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
| <0.001 | Strawberry nevus of skin | NA | BeFree | Detail | |
| <0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
| <0.001 | Hydrosalpinx (disease) | NA | BeFree | Detail | |
| 0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic ... | BeFree | 24891316 | Detail |
| 0.001 | age related macular degeneration | NA | BeFree | Detail | |
| 0.080 | Acute Lung Injury | NA | RGD | Detail | |
| 0.120 | Disease Progression | NA | CTD_human | Detail | |
| <0.001 | Carcinoma, Lewis Lung | NA | BeFree | Detail | |
| 0.003 | macular retinal edema | NA | LHGDN | Detail | |
| <0.001 | Exudative age-related macular degeneration | NA | BeFree | Detail | |
| <0.001 | Metastatic Renal Cell Cancer | NA | BeFree | Detail | |
| <0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | anal carcinoma | NA | BeFree | Detail | |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | secondary acute myeloid leukemia | NA | BeFree | Detail | |
| <0.001 | diffuse astrocytoma | NA | BeFree | Detail | |
| <0.001 | Vascular Neoplasms | VEGFR-1 and its ligands participate in vascular, tumor cell-mediated and immuno-... | BeFree | 25880726 | Detail |
| <0.001 | Prostatic Intraepithelial Neoplasias | NA | BeFree | Detail | |
| <0.001 | Sclerosing stromal tumor | NA | BeFree | Detail | |
| <0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
| <0.001 | anaplastic oligodendroglioma | NA | BeFree | Detail | |
| <0.001 | malignant mesothelioma | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Disseminated Malignant Neoplasm | Moreover, we found that the soluble Flt-1 from SWT neutralized the increased pla... | BeFree | 25895458 | Detail |
| <0.001 | Malignant neoplasm of prostate | VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancer... | BeFree | 25894226 | Detail |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| <0.001 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
| <0.001 | tongue carcinoma | NA | BeFree | Detail | |
| <0.001 | Osteosarcoma of bone | In addition, it was demonstrated that VEGF and VEGFR1 are coexpressed by a subse... | BeFree | 24759089 | Detail |
| 0.002 | Carcinogenesis | NA | BeFree | Detail | |
| 0.001 | prostate carcinoma | VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancer... | BeFree | 25894226 | Detail |
| 0.080 | Choroidal Neovascularization | NA | RGD | Detail | |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| <0.001 | Sentinel node (disorder) | NA | BeFree | Detail | |
| 0.005 | breast carcinoma | Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North In... | BeFree | 25604142 | Detail |
| 0.005 | breast carcinoma | Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 St... | BeFree | 26124351 | Detail |
| 0.005 | breast carcinoma | Here we show that FMS-like tyrosine kinase 1 (Flt1, also known as VEGFR1) labels... | BeFree | 26261265 | Detail |
| <0.001 | Carcinoma of lung | Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic ... | BeFree | 24891316 | Detail |
| <0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
| 0.002 | Pregnancy loss | NA | GAD | Detail | |
| <0.001 | colon carcinoma | VEGFR-1 and its ligands participate in vascular, tumor cell-mediated and immuno-... | BeFree | 25880726 | Detail |
| 0.002 | stomach carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Chronic lung disease | NA | BeFree | Detail | |
| <0.001 | Well Differentiated Oligodendroglioma | NA | BeFree | Detail | |
| <0.001 | Spots on skin | NA | BeFree | Detail | |
| <0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
| <0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
| 0.120 | Drug-Induced Liver Injury | NA | CTD_human | Detail | |
| <0.001 | Advanced cancer | NA | BeFree | Detail | |
| <0.001 | Carcinomatous ascites | NA | BeFree | Detail | |
| <0.001 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
| 0.003 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
| <0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| <0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Myxoid cyst | NA | BeFree | Detail | |
| <0.001 | sarcoma | NA | BeFree | Detail | |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| 0.003 | Hepatic Insufficiency | NA | LHGDN | Detail | |
| <0.001 | Epithelioma | NA | BeFree | Detail | |
| 0.204 | Mammary Neoplasms | Thus, CSF1 is epistatic to FLT1, establishing a link between FLT1 and inflammato... | BeFree,CTD_human,LHGDN,RGD | 26261265 | Detail |
| <0.001 | Angiogenic Switch | NA | BeFree | Detail | |
| 0.003 | Tumor Angiogenesis | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| 0.002 | colorectal cancer | NA | BeFree | Detail | |
| <0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
| <0.001 | Rectal Tumors | NA | BeFree | Detail | |
| <0.001 | Non-Malignant Ascites Adverse Event | NA | BeFree | Detail | |
| <0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | tumor vasculature | NA | BeFree | Detail | |
| <0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| <0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
| <0.001 | Neuroferritinopathy | Interactome analysis identified four PR-genes in signaling pathways whose dysreg... | BeFree | 26149656 | Detail |
| <0.001 | coronary artery disease | NA | BeFree | Detail | |
| 0.004 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | low grade glioma | NA | BeFree | Detail | |
| 0.004 | liver carcinoma | NA | BeFree,LHGDN | Detail | |
| 0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
| <0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
| 0.080 | Neointima | NA | RGD | Detail | |
| 0.200 | Cerebral Hemorrhage | NA | CTD_human,RGD | Detail | |
| 0.003 | myelodysplastic syndrome | NA | BeFree,LHGDN | Detail | |
| 0.003 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Primary myelofibrosis | NA | BeFree | Detail | |
| <0.001 | Colonic Neoplasms | After stratifying by tumor molecular subtype, SNP associations observed for colo... | BeFree | 23794399 | Detail |
| 0.003 | Altitude Sickness | NA | LHGDN | Detail | |
| 0.003 | Anoxia | NA | LHGDN | Detail | |
| 0.001 | arteriosclerosis | (18)F-FLT positron emission tomography imaging may serve as an imaging biomarker... | BeFree | 26394773 | Detail |
| <0.001 | arthritis | NA | BeFree | Detail | |
| <0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
| <0.001 | asphyxia neonatorum | NA | BeFree | Detail | |
| <0.001 | Astrocytoma | NA | BeFree | Detail | |
| 0.001 | atherosclerosis | (18)F-FLT positron emission tomography imaging may serve as an imaging biomarker... | BeFree | 26394773 | Detail |
| <0.001 | Melanoma, B16 | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of breast | Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North In... | BeFree | 25604142 | Detail |
| 0.005 | Malignant neoplasm of breast | Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 St... | BeFree | 26124351 | Detail |
| 0.005 | Malignant neoplasm of breast | Here we show that FMS-like tyrosine kinase 1 (Flt1, also known as VEGFR1) labels... | BeFree | 26261265 | Detail |
| 0.001 | Malignant tumor of colon | VEGFR-1 and its ligands participate in vascular, tumor cell-mediated and immuno-... | BeFree | 25880726 | Detail |
| <0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
| <0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
| 0.002 | Non-small cell lung carcinoma | [(18)F]FLT PET/CT can detect MET-mediated resistance to EGFR TKIs and its revers... | BeFree | 25052479 | Detail |
| 0.002 | Non-small cell lung carcinoma | The expression of VEGFA (particularly in SCC and early stage NSCLC), VEGFC, VEGF... | BeFree | 25773840 | Detail |
| 0.124 | renal cell carcinoma | NA | BeFree,CTD_human,LHGDN | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonar... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In a retrospective collection of 44 cases (14 astrocytoma, 16 ependymoma and 14 medulloblastoma), im... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| PHACTR1, CDKN2B-AS1, LPL, PSRC1, FLT1 and CNNM2 may thus be susceptibility loci for MI in Japanese i... | DisGeNET | Detail |
| Nuclear FGFR2 expression was associated with increased risk of metastasis (odds ratio (OR)=7.61, P=0... | DisGeNET | Detail |
| Lymphocyte-associated VEGFR-1 expression in the invasive front without accompanying autophosphorylat... | DisGeNET | Detail |
| Moreover, we found that the soluble Flt-1 from SWT neutralized the increased placental growth factor... | DisGeNET | Detail |
| Importantly, FLT1 inhibition reduces tumor metastatic efficiency even after initial seeding, suggest... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In addition, it was demonstrated that VEGF and VEGFR1 are coexpressed by a subset of tumor cells in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Discordant results were observed for VEGFR1, p27, and p21 overexpressed in paragangliomas but undere... | DisGeNET | Detail |
| We investigated the expression of p53, Ki-67, Bax, Bcl-2, vascular endothelial growth factor (VEGF)-... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| No significant risk for developing tumor progression was associated with Ki-67, p53, Bax, Bcl-2, VEG... | DisGeNET | Detail |
| The VEGFR-1 is suggested to promote tumor progression. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonar... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| VEGFR-1 and its ligands participate in vascular, tumor cell-mediated and immuno-inflammatory process... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Moreover, we found that the soluble Flt-1 from SWT neutralized the increased placental growth factor... | DisGeNET | Detail |
| VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treate... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In addition, it was demonstrated that VEGF and VEGFR1 are coexpressed by a subset of tumor cells in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treate... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians. | DisGeNET | Detail |
| Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cance... | DisGeNET | Detail |
| Here we show that FMS-like tyrosine kinase 1 (Flt1, also known as VEGFR1) labels a subset of macroph... | DisGeNET | Detail |
| Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonar... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| VEGFR-1 and its ligands participate in vascular, tumor cell-mediated and immuno-inflammatory process... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Thus, CSF1 is epistatic to FLT1, establishing a link between FLT1 and inflammatory responses within ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interactome analysis identified four PR-genes in signaling pathways whose dysregulation is correlate... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| After stratifying by tumor molecular subtype, SNP associations observed for colon cancer were: VEGFA... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| (18)F-FLT positron emission tomography imaging may serve as an imaging biomarker for cell proliferat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| (18)F-FLT positron emission tomography imaging may serve as an imaging biomarker for cell proliferat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians. | DisGeNET | Detail |
| Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cance... | DisGeNET | Detail |
| Here we show that FMS-like tyrosine kinase 1 (Flt1, also known as VEGFR1) labels a subset of macroph... | DisGeNET | Detail |
| VEGFR-1 and its ligands participate in vascular, tumor cell-mediated and immuno-inflammatory process... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| [(18)F]FLT PET/CT can detect MET-mediated resistance to EGFR TKIs and its reversal by MET inhibitors... | DisGeNET | Detail |
| The expression of VEGFA (particularly in SCC and early stage NSCLC), VEGFC, VEGFR1 indicates separat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs9513008 dbSNP
- Genome
- hg19
- Position
- chr13:28,874,483-29,069,282
- Variant Type
- snv
Genome browser